Tag

Gastroparesis

All articles tagged with #gastroparesis

Rare Illness Forces a Mom to Live on $14K-a-Week IV Nutrition
lifestyle1 month ago

Rare Illness Forces a Mom to Live on $14K-a-Week IV Nutrition

Shayla Talei, a 31-year-old mom of two, lives with Complex Regional Pain Syndrome and gastroparesis, a condition that prevents her from digesting solid food. She relies on total parenteral nutrition delivered through a central line, carries a heavy back‑pack for up to 12 hours a day, and spends about $14,000 per week on nutrition before insurance (roughly $1,000 a day). She documents her daily routine on TikTok to explain the realities of living with these conditions and the costs, while noting insurance helps but she’ll always have some medical debt.

Influencer with Paralyzed Stomach Rebutts GLP-1 Link to Condition
celebrity1 month ago

Influencer with Paralyzed Stomach Rebutts GLP-1 Link to Condition

Shayla Talei, a 31-year-old Oklahoma City influencer living with Complex Regional Pain Syndrome and gastroparesis, explains that her severely paralyzed stomach isn’t caused by GLP-1 (she has never used the drug) and that she lost about 100 pounds due to the condition; she relies on total parenteral nutrition and continues to share her daily medical routine with a large TikTok following while facing online criticism.

Living on IV Nutrition: A $14K-Per-Week Lifeline
health1 month ago

Living on IV Nutrition: A $14K-Per-Week Lifeline

A 31-year-old mom, Shayla Talei, lives with Complex Regional Pain Syndrome and gastroparesis, a stomach paralysis that prevents solid food intake. Since mid-2025 she relies on total parenteral nutrition delivered through a central line and carried in a backpack for about 12 hours daily. Before insurance, her TPN-related costs run roughly $1,000 per day, about $14,000 per week, with ongoing medical debt even after insurance helps. Talei shares her routine on social media to document the realities of long-term IV nutrition, highlighting the extraordinary costs and daily impact of living with a rare, debilitating condition.

Influencer With Paralyzed Stomach Refutes GLP-1 Link to Illness (Exclusive)
health1 month ago

Influencer With Paralyzed Stomach Refutes GLP-1 Link to Illness (Exclusive)

Shayla Talei, a 31-year-old Oklahoma City mom living with Complex Regional Pain Syndrome and gastroparesis, has built a large social‑media following by sharing her daily battle with a nearly paralyzed stomach and reliance on total parenteral nutrition, after losing about 100 pounds in eight months before her diagnosis. Some commenters speculated her condition stems from GLP-1 weight‑loss drugs, but Talei insists she never used GLP-1 and emphasizes that gastroparesis can arise from multiple factors, not from something she did to herself.

Concerns Rise Over Side Effects and Costs of Popular Weight-Loss Drugs
health1 year ago

Concerns Rise Over Side Effects and Costs of Popular Weight-Loss Drugs

The article discusses the underreported side effects of the diabetes drug semaglutide (Ozempic), including serious digestive issues like gastroparesis, pancreatitis, and bowel obstruction. It highlights the importance of understanding potential side effects of medications, which are often not fully disclosed in advertisements. Additionally, it addresses the risks associated with the sleeping pill zolpidem (Ambien), which can cause dangerous sleep behaviors such as sleep-driving, leading to accidents.

Weight-Loss Drugs Linked to Severe Stomach Paralysis Risks
health2 years ago

Weight-Loss Drugs Linked to Severe Stomach Paralysis Risks

A landmark court case reveals severe side effects, including gastroparesis and bowel injuries, allegedly caused by weight-loss drugs like Ozempic and Mounjaro. Patients, including Meredith Hotchkiss, claim these drugs have led to life-threatening conditions, leaving some unable to eat solid food and reliant on feeding tubes. Nearly 100 patients have joined the legal action against drugmakers Eli Lilly and Novo Nordisk, who deny the allegations and plan to defend against the claims.

Diabetes Drugs Like Ozempic Linked to Stomach Paralysis Risk
health2 years ago

Diabetes Drugs Like Ozempic Linked to Stomach Paralysis Risk

New studies presented at Digestive Disease Week 2024 have linked popular diabetes and weight loss medications like Ozempic and Wegovy with an increased risk of stomach paralysis (gastroparesis) and other gastrointestinal issues. The research, involving large patient cohorts, found significant increases in the risk of gastroparesis, cholecystitis, and drug-induced pancreatitis among users of GLP-1 receptor agonists. These findings highlight the need for caution and further investigation into the long-term effects of these medications.

Weight Loss Drugs Ozempic and Wegovy Linked to Stomach Paralysis Risks
health2 years ago

Weight Loss Drugs Ozempic and Wegovy Linked to Stomach Paralysis Risks

New studies indicate that users of GLP-1 drugs like Ozempic and Wegovy are more likely to develop gastroparesis, a condition involving delayed stomach emptying. Despite its alarming name, experts emphasize that gastroparesis is a reversible and expected side effect of these medications, which are commonly used for diabetes and obesity treatment.

"Woman Sues Novo Nordisk Over Ozempic's Gastroparesis Side Effects"
health-legal2 years ago

"Woman Sues Novo Nordisk Over Ozempic's Gastroparesis Side Effects"

Caren Elosua is suing Novo Nordisk, the makers of Ozempic, claiming the weight loss drug caused her stomach problems and gastroparesis, alleging that the company was aware of the risks but continued to manufacture it. Several other patients across America have also filed suits against Novo Nordisk, claiming extreme side effects, including life-threatening conditions, from using Ozempic off-label for weight loss. The lawsuits accuse Novo Nordisk of failing to warn them of the risks, and similar claims have been made against Eli Lilly, the maker of Mounjaro.

"Man Sues Over Mounjaro-Induced Gastroparesis and Stomach Paralysis"
health-and-medicine2 years ago

"Man Sues Over Mounjaro-Induced Gastroparesis and Stomach Paralysis"

A 38-year-old man developed gastroparesis, a condition causing stomach paralysis, after taking two doses of Mounjaro, a diabetes medication also used for weight loss. He has filed a lawsuit against the drugmaker Eli Lilly, alleging that he was not adequately warned about the potential for serious, lifelong stomach issues. The law firm representing him, Morgan & Morgan, is investigating over 10,000 potential cases of gastroparesis linked to GLP-1 class drugs like Mounjaro. The man's condition has significantly impacted his diet, work life, and overall well-being.

The Controversy Surrounding Ozempic: Loyalists, Disappointed Users, and Medicare Coverage
health2 years ago

The Controversy Surrounding Ozempic: Loyalists, Disappointed Users, and Medicare Coverage

Drugs like Ozempic, initially developed for diabetes, have gained popularity for weight loss. Loyal users praise its effectiveness, while some businesses report decreased food purchases by customers on the medication. However, there are also reports of adverse effects, such as gastroparesis, a condition where the stomach doesn't empty properly. The FDA recently updated Ozempic's label to include warnings about potential gastrointestinal issues. Novo Nordisk, the drug's manufacturer, emphasizes patient safety as a priority.

The Dark Side of Ozempic: My Incurable Condition Revealed
health2 years ago

The Dark Side of Ozempic: My Incurable Condition Revealed

The author shares their personal experience with gastroparesis, a stomach condition that causes paralysis of the stomach muscles, after taking Ozempic, an injectable diabetes drug used off-label for weight loss. They explain the debilitating symptoms of gastroparesis, the lack of a cure, and the challenges they face in managing their condition. The author cautions against the potential side effects of drugs like Ozempic and emphasizes that no amount of weight loss is worth the suffering caused by gastroparesis.